OCALA, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) today highlighted the significant progress achieved across its pancreatic cancer development program ...
Cursor AI model training reaches a new milestone: a 1.5-trillion-parameter system pre-trained from scratch on xAI’s Colossus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results